- Role of Fenofibrate Use in Dyslipidemia and Related Comorbidities in the Asian Population: A Narrative Review
-
Deerochanawong C, Kim SG, Chang YC
- KMID: 2553589
- Diabetes Metab J.
- 2024 Mar;48(2):184-195.
- doi: 10.4093/dmj.2023.0168
Hypertriglyceridemia and decreased high-density lipoprotein cholesterol (HDL-C) persist despite statin therapy, contributing to residual atherosclerotic cardiovascular disease (ASCVD) risk. Asian subjects are metabolically more susceptible to hypertriglyceridemia than other ethnicities.... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of SGLT-2 Inhibitors in Patients with Type 2 Diabetes Mellitus and Abdominal Obesity: An Asian Perspective and Expert Recommendations
-
Sheu WH, Chan SP, Matawaran , Deerochanawong C, Mithal A, Chan J, Suastika K, Khoo CM, Nguyen HM, Linong J, Luk A, Yoon KH
- KMID: 2470952
- Diabetes Metab J.
- 2020 Feb;44(1):11-32.
- doi: 10.4093/dmj.2019.0208
The prevalence of obesity in Asia is of epidemic proportions, with an estimated 1 billion overweight/obese individuals in the region. The majority of patients with type 2 diabetes mellitus (T2DM)... -
- CITED
-
- Close
- SHARE
-
- Close
